Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Podda

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
FEMS Microbiology Immunology|October 1, 1992
Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune responseR Rappuoli, M Pizza, A Covacci, et al.
Lancet (London, England)|June 27, 2001
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaK G Nicholson, A E Colegate, A Podda, et al.
Medical Microbiology and Immunology|November 30, 2002
Experience with the clinical development of influenza vaccines for potential pandemicsJ M Wood, K G Nicholson, I Stephenson, et al.
Vaccine|August 5, 2000
Dose range evaluation of a new inactivated hepatitis A vaccine administered as a single dose followed by a boosterM Minutello, C Zotti, S Orecchia, et al.
Blood|April 15, 1990
Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosomeR Galanello, M A Melis, A Podda, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|March 1, 1991
[A phase-I clinical trial of a new antitetanus/antidiphtheria vaccine for adults]A Podda, N Vescia, D Donati, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2014
Acute Liver Failure Because of Wilson Disease With Overlapping Autoimmune Hepatitis Features: The Coexistence of Two Diseases?Georgios Loudianos, Antonietta Zappu, Maria B Lepori, et al.
The Turkish Journal of Pediatrics|April 19, 2000
Safety, tolerability and immunogenicity of a Haemophilus influenzae type b vaccine containing aluminum phosphate adjuvant administered at 2, 3 and 4 months of ageG Kanra, S Viviani, K Yurdakök, et al.
Vaccine|August 26, 1999
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderlyS De Donato, D Granoff, M Minutello, et al.
The Journal of Pediatrics|August 1, 1995
Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis VaccineA Podda, G Bona, G Canciani, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
FEMS Microbiology Immunology|October 1, 1992
Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune responseR Rappuoli, M Pizza, A Covacci, et al.
Lancet (London, England)|June 27, 2001
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaK G Nicholson, A E Colegate, A Podda, et al.
Medical Microbiology and Immunology|November 30, 2002
Experience with the clinical development of influenza vaccines for potential pandemicsJ M Wood, K G Nicholson, I Stephenson, et al.
Vaccine|August 5, 2000
Dose range evaluation of a new inactivated hepatitis A vaccine administered as a single dose followed by a boosterM Minutello, C Zotti, S Orecchia, et al.
Blood|April 15, 1990
Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosomeR Galanello, M A Melis, A Podda, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|March 1, 1991
[A phase-I clinical trial of a new antitetanus/antidiphtheria vaccine for adults]A Podda, N Vescia, D Donati, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 9, 2014
Acute Liver Failure Because of Wilson Disease With Overlapping Autoimmune Hepatitis Features: The Coexistence of Two Diseases?Georgios Loudianos, Antonietta Zappu, Maria B Lepori, et al.
The Turkish Journal of Pediatrics|April 19, 2000
Safety, tolerability and immunogenicity of a Haemophilus influenzae type b vaccine containing aluminum phosphate adjuvant administered at 2, 3 and 4 months of ageG Kanra, S Viviani, K Yurdakök, et al.
Vaccine|August 26, 1999
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderlyS De Donato, D Granoff, M Minutello, et al.
The Journal of Pediatrics|August 1, 1995
Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis VaccineA Podda, G Bona, G Canciani, et al.
Pageof 6